{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Preliminary+Efficacy&page=16", "query": { "condition": "Preliminary Efficacy", "page": 16 }, "page_size": 10 }, "pagination": { "page": 16, "page_size": 10, "total_count": 719, "total_pages": 72, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Preliminary+Efficacy&page=17&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Preliminary+Efficacy&page=15&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-24T16:16:41.942Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT07409246", "title": "A Study to Evaluate Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Moves Through the Body in Adult Participants With Multiple Myeloma (MM)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Multiple Myeloma" ], "interventions": [ { "name": "ABBV-438", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AbbVie", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 127, "start_date": "2026-02-27", "completion_date": "2031-11", "has_results": false, "last_update_posted_date": "2026-10-20", "last_synced_at": "2026-10-24T16:16:41.942Z", "location_count": 7, "location_summary": "Duarte, California • Irvine, California • Denver, Colorado + 4 more", "locations": [ { "city": "Duarte", "state": "California" }, { "city": "Irvine", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "Tampa", "state": "Florida" }, { "city": "Newnan", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT07409246" }, { "nct_id": "NCT06719362", "title": "A Clinical Trial to Evaluate the Safety, Tolerability and Clinical Efficacy of M3T01 Monotherapy and in Combination With Pembrolizumab and Other Systemic Therapies", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Advanced Solid Tumors" ], "interventions": [ { "name": "M3T01", "type": "DRUG" }, { "name": "Pembrolizumab", "type": "DRUG" }, { "name": "Chemoradiation", "type": "RADIATION" }, { "name": "FOLFOX regimen", "type": "DRUG" } ], "intervention_types": [ "DRUG", "RADIATION" ], "sponsor": "Providence Health & Services", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 110, "start_date": "2025-06-17", "completion_date": "2030-02", "has_results": false, "last_update_posted_date": "2026-07-23", "last_synced_at": "2026-10-24T16:16:41.942Z", "location_count": 1, "location_summary": "Portland, Oregon", "locations": [ { "city": "Portland", "state": "Oregon" } ], "official_url": "https://clinicaltrials.gov/study/NCT06719362" }, { "nct_id": "NCT07046923", "title": "A Study of LY4175408 in Participants With Advanced Cancer", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Carcinoma, Non-Small-Cell Lung", "Small Cell Lung Carcinoma", "Endometrial Neoplasms", "Neoplasm Metastasis", "Triple Negative Breast Cancer" ], "interventions": [ { "name": "LY4175408", "type": "DRUG" }, { "name": "Pembrolizumab", "type": "DRUG" }, { "name": "Carboplatin", "type": "DRUG" }, { "name": "Cisplatin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 240, "start_date": "2025-07-28", "completion_date": "2030-07", "has_results": false, "last_update_posted_date": "2026-06-23", "last_synced_at": "2026-10-24T16:16:41.942Z", "location_count": 15, "location_summary": "Stanford, California • Orlando, Florida • Sarasota, Florida + 11 more", "locations": [ { "city": "Stanford", "state": "California" }, { "city": "Orlando", "state": "Florida" }, { "city": "Sarasota", "state": "Florida" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Indianapolis", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT07046923" }, { "nct_id": "NCT05293912", "title": "SG2501 Safety Study in Subjects with Relapsed or Refractory Hematological Malignancies and Lymphoma.", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Hematological Malignancy", "Lymphoma" ], "interventions": [ { "name": "SG2501", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Hangzhou Sumgen Biotech Co., Ltd.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 2, "start_date": "2023-03-03", "completion_date": "2023-06-30", "has_results": false, "last_update_posted_date": "2025-03-18", "last_synced_at": "2026-10-24T16:16:41.942Z", "location_count": 8, "location_summary": "Atlanta, Georgia • Hackensack, New Jersey • Hawthorne, New York + 5 more", "locations": [ { "city": "Atlanta", "state": "Georgia" }, { "city": "Hackensack", "state": "New Jersey" }, { "city": "Hawthorne", "state": "New York" }, { "city": "Charlotte", "state": "North Carolina" }, { "city": "Durham", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT05293912" }, { "nct_id": "NCT01761019", "title": "A Study to Determine the Efficacy of Taclonex Topical Suspension as a Supplement to Non-biologic Systemic Therapy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Psoriasis" ], "interventions": [ { "name": "Taclonex Topical Suspension", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Pittsburgh", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 8, "start_date": "2013-01", "completion_date": "2014-09", "has_results": true, "last_update_posted_date": "2016-09-21", "last_synced_at": "2026-10-24T16:16:41.942Z", "location_count": 1, "location_summary": "Pittsburgh, Pennsylvania", "locations": [ { "city": "Pittsburgh", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT01761019" }, { "nct_id": "NCT05846932", "title": "Preliminary Efficacy of Occupational Therapy Integrating Horses on Self-regulation in Youth With Autism", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Autism Spectrum Disorder" ], "interventions": [ { "name": "OTEE HORS", "type": "BEHAVIORAL" }, { "name": "OT Clinic", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Colorado State University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "6 Years", "maximum_age": "11 Years", "sex": "ALL", "summary": "6 Years to 11 Years" }, "enrollment_count": 72, "start_date": "2023-03-21", "completion_date": "2025-11-01", "has_results": true, "last_update_posted_date": "2026-10-02", "last_synced_at": "2026-10-24T16:16:41.942Z", "location_count": 1, "location_summary": "Denver, Colorado", "locations": [ { "city": "Denver", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT05846932" }, { "nct_id": "NCT02040532", "title": "Gabapentin for Insomnia Symptoms and Nighttime Vasomotor Symptoms (VMS) in Peri- and Postmenopausal Women", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Menopause", "Hot Flashes", "Vasomotor Disturbance" ], "interventions": [ { "name": "Gabapentin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Massachusetts General Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": "65 Years", "sex": "FEMALE", "summary": "40 Years to 65 Years · Female only" }, "enrollment_count": 32, "start_date": "2014-01", "completion_date": "2015-08", "has_results": true, "last_update_posted_date": "2019-08-07", "last_synced_at": "2026-10-24T16:16:41.942Z", "location_count": 2, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT02040532" }, { "nct_id": "NCT01688440", "title": "ETCare: Safety and Preliminary Efficacy Trial", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Respiratory Distress Syndrome, Newborn" ], "interventions": [ { "name": "#1 Respiratory Care Solution", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Intermountain Health Care, Inc.", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 10, "start_date": "2005-06", "completion_date": "2005-09", "has_results": false, "last_update_posted_date": "2012-09-19", "last_synced_at": "2026-10-24T16:16:41.942Z", "location_count": 2, "location_summary": "Ogden, Utah • Salt Lake City, Utah", "locations": [ { "city": "Ogden", "state": "Utah" }, { "city": "Salt Lake City", "state": "Utah" } ], "official_url": "https://clinicaltrials.gov/study/NCT01688440" }, { "nct_id": "NCT06271252", "title": "A Study to Evaluate the Safety, PK/PD of (OriCAR-017) in Subjects With RR/MM - RIGEL Study", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Neoplasms, Plasma Cell", "Neoplasms by Histologic Type", "Neoplasms", "Hemostatic Disorders", "Vascular Diseases", "Cardiovascular Diseases", "Paraproteinemias", "Blood Protein Disorders", "Hematologic Diseases", "Hemorrhagic Disorders", "Lymphoproliferative Disorders", "Immunoproliferative Disorders", "Immune System Diseases", "Multiple Myeloma" ], "interventions": [ { "name": "OriCAR-017", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "OriCell Therapeutics Co., Ltd.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 81, "start_date": "2024-04-03", "completion_date": "2028-04-12", "has_results": false, "last_update_posted_date": "2024-08-02", "last_synced_at": "2026-10-24T16:16:41.942Z", "location_count": 1, "location_summary": "Atlanta, Georgia", "locations": [ { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT06271252" }, { "nct_id": "NCT07693751", "title": "A Study to Assess Safety and Efficacy of SOT109 in Patients With Advanced Unresectable or Metastatic Colorectal Cancer", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Colorectal Cancer (Locally Advanced or Metastatic)" ], "interventions": [ { "name": "SOT109", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "SOTIO Biotech a.s.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 100, "start_date": "2026-08-12", "completion_date": "2028-07-04", "has_results": false, "last_update_posted_date": "2026-09-21", "last_synced_at": "2026-10-24T16:16:41.942Z", "location_count": 2, "location_summary": "Houston, Texas • Faifax, Virginia", "locations": [ { "city": "Houston", "state": "Texas" }, { "city": "Faifax", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT07693751" } ] }